Study of a new medicine for vitiligo
Part of Skin clinical trials.
This trial tests a new medicine called TEV-53408 to see if it can help with vitiligo, a condition that causes white patches on the skin. It may help by restoring skin color, and the study will check how safe and effective it is.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had vitiligo for at least 3 months.
- Your weight is within a healthy range for your height (BMI between 18.5 and 40).
- If you are a woman, you are either not able to have children or you agree to use a very reliable birth control method, and you are not pregnant or breastfeeding.
- If you are a man, you agree not to donate sperm and to use a condom or stay abstinent during the trial.
- You agree to stop all other vitiligo treatments for the time you are in the study.
- You agree to protect your skin from the sun and avoid tanning booths and sun lamps.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called LY4005130 for non-segmental vitiligo, a skin condition where patches lose pigment (color). The trial aims to see if this drug can help restore skin color and stop the spread of white patches.
This trial tests an ointment called MH004 to see if it helps repigment white patches in people with non-segmental vitiligo (the most common type). It focuses on patches on the face and body.
This study tests a new medicine called FB102 for people with non-segmental vitiligo. It aims to see if the drug is safe and helps restore skin color.
This trial tests a new medicine called GR2301, given as an injection, combined with light therapy, to see if it can help people with vitiligo. It aims to improve skin color in affected areas, especially on the face.
This trial tests a daily pill (upadacitinib) to see if it can improve vitiligo after an initial treatment (NECS). It is for people whose vitiligo is stable and covers a limited area.
This trial tests a new cream for vitiligo on the face or neck. It aims to see if the cream can help bring color back to white patches.
Hear when a new Vitiligo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.